Greenwich LifeSciences
GLSI
#8391
Rank
NZ$0.51 B
Marketcap
NZ$35.19
Share price
-2.73%
Change (1 day)
142.44%
Change (1 year)

Earnings for Greenwich LifeSciences (GLSI)

Earnings in 2026 (TTM): -NZ$37.96 Million

According to Greenwich LifeSciences's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$34.11 Million a decrease over its 2024 earnings that were of -NZ$29.27 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Greenwich LifeSciences from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$37.96 Million11.28%
2025 -NZ$34.11 Million16.52%
2024 -NZ$29.27 Million71.66%
2023 -NZ$17.06 Million16.01%
2022 -NZ$14.7 Million74.87%
2021 -NZ$8.41 Million146.7%
2020 -NZ$3.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-NZ$4.55 Million-88.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-NZ$0.14 Billion 234.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-NZ$0.41 Billion 921.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-NZ$0.17 Billion 311.39% Jersey